Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
Journal of Surgical Oncology
|
January 14, 2021
The role of <sup>18</sup> F-FDG PET/CT in retroperitoneal sarcomas-A multicenter retrospective study
Suren Subramaniam, Jason Callahan, Mathias Bressel, et al.
Technology in Cancer Research & Treatment
|
January 11, 2015
Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning
Shankar Siva, Thomas Devereux, David L Ball, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 22, 2018
What <sup>18</sup>F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 11, 2025
A prospective study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer
Neil D Wallace, Mathias Bressel, Nick Hardcastle, et al.
BJU International
|
June 28, 2025
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma
Muhammad Ali, Mathias Bressel, David Chang, et al.
BJU International
|
March 8, 2021
UpFrontPSMA: a randomized phase 2 study of sequential <sup>177</sup> Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)
Nattakorn Dhiantravan, Louise Emmett, Anthony M Joshua, et al.
European Urology
|
September 20, 2018
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
Shankar Siva, Mathias Bressel, Declan G Murphy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2022
Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases
Shankar Siva, Gavin Jones, Mathias Bressel, et al.
European Urology Open Science
|
October 3, 2022
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
Cristian Udovicich, Jason Callahan, Mathias Bressel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 27, 2025
SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial
Constanza Vargas, Joe Carrello, Mathias Bressel, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
Journal of Surgical Oncology
|
January 14, 2021
The role of <sup>18</sup> F-FDG PET/CT in retroperitoneal sarcomas-A multicenter retrospective study
Suren Subramaniam, Jason Callahan, Mathias Bressel, et al.
Technology in Cancer Research & Treatment
|
January 11, 2015
Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning
Shankar Siva, Thomas Devereux, David L Ball, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 22, 2018
What <sup>18</sup>F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 11, 2025
A prospective study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer
Neil D Wallace, Mathias Bressel, Nick Hardcastle, et al.
BJU International
|
June 28, 2025
Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma
Muhammad Ali, Mathias Bressel, David Chang, et al.
BJU International
|
March 8, 2021
UpFrontPSMA: a randomized phase 2 study of sequential <sup>177</sup> Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naïve prostate cancer (clinical trial protocol)
Nattakorn Dhiantravan, Louise Emmett, Anthony M Joshua, et al.
European Urology
|
September 20, 2018
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
Shankar Siva, Mathias Bressel, Declan G Murphy, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2022
Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases
Shankar Siva, Gavin Jones, Mathias Bressel, et al.
European Urology Open Science
|
October 3, 2022
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
Cristian Udovicich, Jason Callahan, Mathias Bressel, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 27, 2025
SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial
Constanza Vargas, Joe Carrello, Mathias Bressel, et al.
Page
of 14